查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598833

血管闭合装置市场：按产品、最终用户划分 - 2025-2030 年全球预测

Vascular Closure Device Market by Product (Active Approximators, External Hemostatic Devices, Passive Approximators), End-User (Acute Care Facilities, Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，血管闭合装置市场价值为15.9亿美元，预计到2024年将达到17.1亿美元，复合年增长率为7.51%，到2030年将达到26.5亿美元。

血管闭合装置市场包括设计用于在插管后密封血管开口、减少出血并加速癒合的医疗设备。这些设备对于血管造影术、血管成形术等介入性手术或需要动脉通路的手术至关重要，可促进快速止血并允许患者早期下床活动。对血管闭合装置的需求在于它们能够提高患者的舒适度、减少手术时间、最大限度地减少血肿等併发症，并允许患者儘早出院。典型的最终用户包括医院、门诊手术中心和导管实验室，其中效率和病患周转率非常重要。

主要市场统计
基准年[2023] 15.9亿美元
预测年份 [2024] 17.1亿美元
预测年份 [2030] 26.5亿美元
复合年增长率（%） 7.51%

心血管疾病的增加、微创手术的进步以及患者对恢復更快的手术的偏好增加推动了市场成长。此外，世界人口老化和医疗保健成本上升进一步推动了需求。开拓成本效益、环保的电器和解决新兴市场未满足的需求存在潜在的商机。可生物分解性降解封闭装置的创新以及用于即时监控和提高有效性的智慧技术的整合也可能提供竞争优势。

然而，市场面临严格的法律规范和先进设备的高成本的限制，这可能会阻碍采用率，特别是在价格敏感地区。此外，由于这些设备需要熟练的劳动力来操作，因此也存在操作挑战。

在创新方面，研发应着重于开发能够改善患者治疗结果同时具有环境永续的材料。智慧型设备技术有望实现即时监控并提高闭合技术的准确性。业务成长也可能来自于开拓未渗透的市场以及透过策略伙伴关係扩大分销网络。

总体而言，血管闭合装置市场存在巨大的商机，但解决监管、成本和营运挑战至关重要。公司应该投资于持续的研发，以促进产品差异化，并利用技术进步来保持在这个不断发展的市场的前沿。

市场动态：揭示快速发展的血管闭合装置市场的关键市场洞察

供需的动态交互作用正在改变血管闭合装置市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球心血管疾病盛行率不断上升
    • 股动脉心导管检查日益普及
    • 提高VCD成功率并缩短止血时间
  • 市场限制因素
    • 相对较高的手术成本和病人对使用桡动脉通路进行介入手术的偏好
  • 市场机会
    • 大直径血管闭合装置日益受到关注
    • 开发 VCD 以解决患者不适和长时间卧床等併发症
  • 市场挑战
    • 产品召回和故障的可能性以及与 VCD 相关的风险

波特五力：驾驭血管闭合装置市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解血管闭合装置市场的外部影响

外部宏观环境因素在塑造血管闭合装置市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解血管闭合器械市场的竞争状况

血管闭合装置市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV定位矩阵血管闭合装置市场供应商绩效评估

FPNV定位矩阵是评估血管闭合装置市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划血管闭合装置市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对血管闭合装置市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球心血管疾病发生率增加
      • 股动脉心导管检查日益普及
      • 提高VCD成功率，缩短止血时间
    • 抑制因素
      • 手术费用相对较高，患者倾向选择以桡动脉路径的介入性手术。
    • 机会
      • 大直径血管闭合装置日益受到关注
      • 开发 VCD 以解决患者不适和长时间卧床等併发症
    • 任务
      • 产品召回和故障的可能性以及 VCD 相关风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章血管闭合装置市场：副产品

  • 主动逼近器
    • 基于夹子的设备
    • 缝合装置
  • 外部止血装置
  • 被动逼近器
    • 胶原蛋白塞
    • 压缩辅助装置
    • 密封剂或凝胶设备

第七章血管闭合装置市场：依最终使用者分类

  • 急诊设施
  • 诊所
  • 医院

第八章北美和南美血管闭合装置市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太血管闭合装置市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲血管闭合装置市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Cardinal Health, Inc.
  • Cardiva Medical, Inc.
  • Cordis Corporation
  • INVAMED
  • Medtronic PLC
  • Morris Innovative, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Tricol Biomedical, Inc.
  • TZ Medical, Inc
  • Vasorum Ltd.
  • Veryan Medical Ltd
  • Vivasure Medical Ltd.
  • WL Gore & Associates
Product Code: MRR-ED54C46E8A80

The Vascular Closure Device Market was valued at USD 1.59 billion in 2023, expected to reach USD 1.71 billion in 2024, and is projected to grow at a CAGR of 7.51%, to USD 2.65 billion by 2030.

The vascular closure device market encompasses medical devices designed to seal openings in blood vessels following catheterization procedures, reducing bleeding and promoting faster healing. These devices are critical for interventional procedures like angiography, angioplasty, or procedures that require arterial access, facilitating quicker hemostasis and enabling early ambulation of patients. The necessity of vascular closure devices lies in their ability to enhance patient comfort, reduce procedure time, minimize complications such as hematoma, and enable faster discharge from medical facilities. Key end-users include hospitals, ambulatory surgical centers, and catheterization labs, where efficiency and patient turnover are critical.

KEY MARKET STATISTICS
Base Year [2023] USD 1.59 billion
Estimated Year [2024] USD 1.71 billion
Forecast Year [2030] USD 2.65 billion
CAGR (%) 7.51%

Market growth is propelled by increasing incidences of cardiovascular diseases, advancements in minimally invasive procedures, and rising patient preference for surgeries with quicker recovery times. Moreover, the aging global population and heightened healthcare expenditure further drive demand. Potential opportunities exist in developing cost-efficient, eco-friendly devices and addressing unmet needs in emerging markets. Innovations in biodegradable closure devices and integration of smart technologies for real-time monitoring and enhanced efficacy could also provide a competitive edge.

However, the market faces limitations due to stringent regulatory frameworks and the high cost of advanced devices, which could impede adoption rates, particularly in price-sensitive regions. Furthermore, the skilled labor required to operate these devices poses an operational challenge.

In terms of innovation, research should focus on developing materials that improve patient outcomes while being environmentally sustainable. Smart device technology holds promise for real-time monitoring and improved precision in closure techniques. Business growth may also come from tapping into underpenetrated markets and forming strategic partnerships to expand distribution networks.

Overall, while the vascular closure device market presents significant opportunities, addressing regulatory, cost, and operational challenges is pivotal. Companies should invest in continuous R&D to foster product differentiation and leverage technological advancements to remain at the forefront of this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Closure Device Market

The Vascular Closure Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of cardiovascular diseases globally
    • Rising popularity of femoral artery cardiac catheterization
    • Growing success rate of VCDs and short hemostasis time
  • Market Restraints
    • Relatively high cost of the procedure and patients' predilection for interventional procedures using radial artery access
  • Market Opportunities
    • Emerging concentration on large-bore vascular closure devices
    • Development of VCDs to tackle complications such as patient discomfort and prolonged bed rest
  • Market Challenges
    • Probability of product recalls and failure coupled with risks related to VCDs

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Closure Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Closure Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Closure Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Closure Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Closure Device Market

A detailed market share analysis in the Vascular Closure Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Closure Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Closure Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Closure Device Market

A strategic analysis of the Vascular Closure Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Closure Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Cardinal Health, Inc., Cardiva Medical, Inc., Cordis Corporation, INVAMED, Medtronic PLC, Morris Innovative, Inc., Teleflex Incorporated, Terumo Corporation, Tricol Biomedical, Inc., TZ Medical, Inc, Vasorum Ltd., Veryan Medical Ltd, Vivasure Medical Ltd., and W. L. Gore & Associates.

Market Segmentation & Coverage

This research report categorizes the Vascular Closure Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Active Approximators, External Hemostatic Devices, and Passive Approximators. The Active Approximators is further studied across Clip-Based Devices and Suture-Based Devices. The Passive Approximators is further studied across Collagen Plugs, Compression-Assist Devices, and Sealant- or Gel-Based Devices.
  • Based on End-User, market is studied across Acute Care Facilities, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cardiovascular diseases globally
      • 5.1.1.2. Rising popularity of femoral artery cardiac catheterization
      • 5.1.1.3. Growing success rate of VCDs and short hemostasis time
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of the procedure and patients' predilection for interventional procedures using radial artery access
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging concentration on large-bore vascular closure devices
      • 5.1.3.2. Development of VCDs to tackle complications such as patient discomfort and prolonged bed rest
    • 5.1.4. Challenges
      • 5.1.4.1. Probability of product recalls and failure coupled with risks related to VCDs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Closure Device Market, by Product

  • 6.1. Introduction
  • 6.2. Active Approximators
    • 6.2.1. Clip-Based Devices
    • 6.2.2. Suture-Based Devices
  • 6.3. External Hemostatic Devices
  • 6.4. Passive Approximators
    • 6.4.1. Collagen Plugs
    • 6.4.2. Compression-Assist Devices
    • 6.4.3. Sealant- or Gel-Based Devices

7. Vascular Closure Device Market, by End-User

  • 7.1. Introduction
  • 7.2. Acute Care Facilities
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas Vascular Closure Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vascular Closure Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Vascular Closure Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Cardinal Health, Inc.
  • 3. Cardiva Medical, Inc.
  • 4. Cordis Corporation
  • 5. INVAMED
  • 6. Medtronic PLC
  • 7. Morris Innovative, Inc.
  • 8. Teleflex Incorporated
  • 9. Terumo Corporation
  • 10. Tricol Biomedical, Inc.
  • 11. TZ Medical, Inc
  • 12. Vasorum Ltd.
  • 13. Veryan Medical Ltd
  • 14. Vivasure Medical Ltd.
  • 15. W. L. Gore & Associates

LIST OF FIGURES

  • FIGURE 1. VASCULAR CLOSURE DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR CLOSURE DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR CLOSURE DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR CLOSURE DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLIP-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SUTURE-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY EXTERNAL HEMOSTATIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COMPRESSION-ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT- OR GEL-BASED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACUTE CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACTIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PASSIVE APPROXIMATORS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023